|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07F 9/6561 | (2006.01) |
| C07F 9/65616 | (2013.01) | ||
| A61K 31/685 | (2006.01) | ||
| A61K 31/675 | (2013.01) | ||
| A61P 31/18 | (2006.01) | ||
| A61P 31/18 | (2018.01) | ||
| A61P 31/20 | (2006.01) | ||
| A61P 31/20 | (2018.01) |
| (11) | Patento numeris | 3577125 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18705239.4 |
| Europos patento paraiškos padavimo data | 2018-01-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-12-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-05-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/015770 |
| Data | 2018-01-29 |
| (87) | Numeris | WO 2018/144390 |
| Data | 2018-08-09 |
| (30) | Numeris | Data | Šalis |
| 201762452428 P | 2017-01-31 | US |
| (72) |
LAI, Chiajen , US
SHI, Bing , US
STRICKLEY, Robert, G. , US
|
| (73) |
Gilead Sciences, Inc. ,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | CRYSTALLINE FORMS OF TENOFOVIR ALAFENAMIDE |
| CRYSTALLINE FORMS OF TENOFOVIR ALAFENAMIDE |